Please wait while the formulary information is being retrieved.
AGRYLIN (ANAGRELIDE HCL)
- Essential thrombocytosis
- Thrombocytosis in myeloproliferative disease
0.5 mg capsule
- 2 capsules (1 mg) by oral route 2 times per day
1 mg capsule
- 1 capsule (1 mg) by oral route 2 times per day
anagrelide 0.5 mg capsule
- 2 capsules (1 mg) by oral route 2 times per day
anagrelide 1 mg capsule
- 1 capsule (1 mg) by oral route 2 times per day
0.5 mg capsule
- 2 capsules (1 mg) by oral route 2 times per day
Essential thrombocytosis
- 1 capsule (0.5 mg) by oral route 4 times per day
- 1 capsule (0.5 mg) by oral route 3 times per day
- 2 capsules (1 mg) by oral route 3 times per day
- 2 capsules (1 mg) by oral route 2 times per day
- 2 capsules (1 mg) by oral route 4 times per day
Thrombocytosis in myeloproliferative disease
- 1 capsule (0.5 mg) by oral route 4 times per day
- 1 capsule (0.5 mg) by oral route 3 times per day
- 2 capsules (1 mg) by oral route 3 times per day
- 2 capsules (1 mg) by oral route 2 times per day
- 2 capsules (1 mg) by oral route 4 times per day
- None
Contraindicated
- Added Strength Headache Relief
- Added Strength Pain Reliever
- Adult Low Dose Aspirin
- Aggrenox
- Alka-seltzer
- Alka-seltzer Extra Strength
- Alka-seltzer Original
- Alka-seltzer Plus C/c(pe,dm)
- Alka-seltzer Plus Cold (pe)
- Alka-seltzer Plus Day-night
- Alka-seltzer Plus Night
- Alka-seltzer Pm
- Anacin
- Anacin Maximum Strength
- Analgesic
- Antacid & Pain Relief
- ASA-acetaminophen-caff-buffers
- ASA-acetaminophen-salicyl-caff
- Ascomp With Codeine
- Aspir-81
- Aspir-low
- Aspir-trin
- aspirin
- Aspirin Childrens
- Aspirin Low Dose
- Aspirin Low-strength
- aspirin, buffered
- aspirin-acetaminophen-caffeine
- aspirin-caffeine
- aspirin-calcium carbonate
- aspirin-diphenhydramine
- aspirin-diphenhydramine citrat
- aspirin-sod bicarb-citric acid
- Back & Body Pain Reliever
- Bayer Advanced
- Bayer Aspirin
- Bayer Aspirin (with Caffeine)
- Bayer Back & Body
- Bayer Chewable Aspirin
- Bayer Childrens Aspirin
- Bayer Plus Extra Strength
- Bayer Pm
- Bc
- Bc Arthritis
- Buffered Aspirin
- Bufferin
- Butalbital Compound W/codeine
- Butalbital Compound-codeine
- butalbital-aspirin-caffeine
- carisoprodol-ASA-codeine
- carisoprodol-aspirin
- Child Aspirin
- Children's Aspirin
- chlorphen-phenyleph-DM-aspirin
- chlorphenir-phenylephrn-aspirn
- codeine-butalbital-ASA-caff
- Cold Relief
- Cold Relief Plus
- dihydrocodeine-aspirin-caff
- dipyridamole-aspirin
- doxylamine-phenylep-DM-aspirin
- E.c. Prin
- Ecotrin
- Ecotrin Low Strength
- Efferves Pain Relief Antacid
- Effervescent Antacid
- Effervescent Pain Relief
- Effervescent Pain Reliever
- Endodan
- Enteric Coated Aspirin
- Excedrin Extra Strength
- Excedrin Migraine
- Extra Strength Bayer
- Fiorinal
- Fiorinal-codeine #3
- Goody's Extra Strength
- Goody's Migraine Relief
- Headache Formula
- Headache Formula Added Str
- Headache Relief
- Kaletra
- Levacet
- Lite Coat Aspirin
- Lo-dose Aspirin
- lopinavir-ritonavir
- Medi-seltzer
- Migraine Formula
- Migraine Pain Reliever
- Migraine Relief
- Orphenadrine Compound Forte
- Orphenadrine Compound-ds
- orphenadrine-ASA-caffeine
- oxycodone-aspirin
- Pain Relief
- Pain Relief Extra Strength
- Pain Reliever
- Pain Reliever Extra Strength
- Pain Reliever Plus
- Pain-off
- Pamprin Max
- PE-DM-ASA/doxyla-PE-DM-ASA
- Percodan
- St Joseph Aspirin
- St. Joseph Aspirin
- Super Pain Relief
- Synalgos-dc
- Tri-buffered Aspirin
- Vanquish
- Women's Aspirin With Calcium
Severe
Moderate
- None
- Congenital long QT syndrome
- Lactating mother
- Torsades de pointes
- Ventricular tachycardia
Contraindicated
- Chronic heart failure
- Disease of liver
- Eosinophilic pneumonia
- High output heart failure
- Hypocalcemia
- Hypokalemia
- Hypomagnesemia
- Interstitial lung disease
- Prolonged QT interval
Severe
Moderate
- Anemia
- Increased risk of bleeding
- Pulmonary hypertension
- Thrombocytopenic disorder
AGRYLIN (ANAGRELIDE HCL)
- Essential thrombocytosis
- Thrombocytosis in myeloproliferative disease
- Pulmonary infiltrates
- Acute abdominal pain
- Anorexia
- Back pain
- Chest pain
- Cough
- Diarrhea
- Dizziness
- Dyspepsia
- Dyspnea
- Edema
- Fever
- Flatulence
- General weakness
- Headache disorder
- Malaise
- Nausea
- Pain
- Palpitations
- Paresthesia
- Peripheral edema
- Pruritus of skin
- Tachycardia
- Vomiting
More Frequent
Severe
Less Severe
- Acute myocardial infarction
- Angina
- Asthma
- Atrial fibrillation
- Bronchitis
- Cardiac arrhythmia
- Cardiomegaly
- Cardiomyopathy
- Cerebrovascular accident
- Chronic heart failure
- Complete atrioventricular block
- Gastrointestinal hemorrhage
- Hemorrhage
- Pericarditis
- Pneumonia
- Thrombocytopenic disorder
- Acute confusion
- Amblyopia
- Anemia
- Aphthous stomatitis
- Arthralgias
- Black tarry stools
- Chills
- Constipation
- Cramps in legs
- Dehydration
- Depression
- Diplopia
- Drowsy
- Dysuria
- Ecchymosis
- Epistaxis
- Eructation
- Flu-like symptoms
- Gastritis
- Hematuria
- Hypertension
- Hypotension
- Insomnia
- Lymphadenopathy
- Memory impairment
- Myalgias
- Nervousness
- Orthostatic hypotension
- Pharyngitis
- Rhinitis
- Skin photosensitivity
- Skin rash
- Syncope
- Tinnitus
- Vasodilation of blood vessels
- Visual changes
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Abnormal hepatic function tests
- Eosinophilic pneumonia
- Gastrointestinal ulcer
- Hepatitis
- Interstitial lung disease
- Interstitial nephritis
- Leukocytosis
- Pancreatitis
- Pleural effusions
- Prolonged QT interval
- Pulmonary fibrosis
- Pulmonary hypertension
- Renal failure
- Seizure disorder
- Supraventricular tachycardia
- Torsades de pointes
- Ventricular tachycardia
Less Severe
- Alopecia
- Hypesthesia
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
Anagrelide
Safety and efficacy not established in age < 7 years.
- 1 Day – 7 Years
- Safety and efficacy not established in age < 7 years.
Anagrelide
- Severity Level:
2
- Additional Notes: Avail human data show no inc risk for major birth defects; dev tox in animals.
Contraindicated
Anagrelide
Insufficient human data; potential for serious adv effects in nursing infant
| General | Excretion Potential | Effect on Infant | Notes |
| Drug should not be given to breast feeding mothers | Unknown | Not known; no or inclusive data | Insufficient human data; potential for serious adv effects in nursing infant |
Precaution Exists
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
| Essential thrombocytosis | |
| D47.3 | Essential (hemorrhagic) thrombocythemia |
| Thrombocytosis in myeloproliferative disease | |
| D47.1 | Chronic myeloproliferative disease |
| D47.3 | Essential (hemorrhagic) thrombocythemia |
| 0-9 | A-Z |
|---|---|
| D47.1 | Chronic myeloproliferative disease |
| D47.3 | Essential (hemorrhagic) thrombocythemia |
| D47.3 | Essential (hemorrhagic) thrombocythemia |
Formulary Reference Tool